Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.
Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.
Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.
Form 4 Filing Details - Insider Trading Activity at Tempus AI
On June 16, 2025, Andrew Polovin, EVP and General Counsel of Tempus AI, executed a sale of 1,423 shares of Class A Common Stock at $72.13 per share. The transaction was conducted under a Rule 10b5-1 trading plan established on September 6, 2024.
Following the transaction, Polovin retains direct beneficial ownership of 137,454 shares of Class A Common Stock. Key transaction details:
- Transaction Type: Sale (S)
- Total Value: Approximately $102,641
- Trading Plan: Executed under pre-established 10b5-1 plan
- Ownership: Direct
This insider sale represents a relatively small portion (approximately 1%) of Polovin's total holdings in the company, suggesting routine portfolio management rather than a significant shift in position.